Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Item
http://www.wikidata.org/entity/Q37490193
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myelomaCD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implications.When to recommend allogeneic transplant in multiple myeloma.Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation.Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model.Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017.
P2860

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Item
http://www.wikidata.org/entity/Q37490193
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictors of prolonged surviv ...... antation for multiple myeloma.
@en
Predictors of prolonged surviv ...... antation for multiple myeloma.
@nl
type
label
Predictors of prolonged surviv ...... antation for multiple myeloma.
@en
Predictors of prolonged surviv ...... antation for multiple myeloma.
@nl
prefLabel
Predictors of prolonged surviv ...... antation for multiple myeloma.
@en
Predictors of prolonged surviv ...... antation for multiple myeloma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Predictors of prolonged surviv ...... antation for multiple myeloma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932